CPT 0522U: Tissue-Specific Markers for Early Diagnosis of Sjögren’s Disease

CPT code 0522U designates a Proprietary Laboratory Analyses (PLA) blood test from KSL Diagnostics Inc. that targets tissue-specific antibodies — carbonic anhydrase VI, parotid-specific protein, and salivary protein 1 (SP1) — using chemiluminescence to support early diagnosis of Sjögren’s disease. As a PLA code, 0522U applies only to this unique test and signals growing use of proprietary molecular diagnostics in autoimmune disease evaluation.

Key national payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Coverage and reimbursement approaches for PLA tests vary across payers, with implications for lab adoption and clinician ordering patterns.

Readers will find a concise overview of the clinical purpose and service setting for the test, payer inclusion in the analysis, and the types of benchmarks and policy topics typically relevant to PLA codes — including coverage policies, coding guidance, and utilization context for early Sjögren’s diagnosis. The publication does not provide state-specific guidance and focuses on national relevance for payers, laboratorians, and clinical stakeholders.

Billing Code Overview

CPT code 0522U is a Proprietary Laboratory Analyses (PLA) code for a single, manufacturer-specific blood test: Tissue Specific Markers for Early Diagnosis of Sjögren’s Disease from KSL Diagnostics Inc. The test detects antibodies to carbonic anhydrase VI, parotid–specific protein, and salivary protein 1 (SP1) using chemiluminescence to assist in the early diagnosis of Sjögren’s disease.

Service Type: Proprietary laboratory blood test for early autoimmune disease diagnosis

Typical Site of Service: Clinical laboratory or outpatient phlebotomy collection site

Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.

Clinical Context

A 42-year-old woman presents to a rheumatology clinic with a 6-month history of dry eyes, dry mouth, intermittent parotid gland swelling, and fatigue. Initial evaluation includes focused history, ocular surface testing (Schirmer test), and serologic testing for common Sjögren’s antibodies. The clinician orders the proprietary laboratory test 0522U (Tissue Specific Markers for Early Diagnosis of Sjögren’s Disease from KSL Diagnostics Inc.) to detect antibodies to carbonic anhydrase VI, parotid-specific protein, and salivary protein 1 (SP1) using chemiluminescence.

Specimen collection is a routine peripheral blood draw performed in the outpatient laboratory or clinic (typical site of service: outpatient laboratory or physician office). The specimen is sent to the performing laboratory; 0522U is reported by the performing lab when the proprietary assay yields results. Results are reviewed by the ordering rheumatologist or primary care clinician as part of the diagnostic workup for suspected Sjögren’s disease, integrated with clinical exam, ocular testing, standard autoimmune serologies, and imaging or biopsy if indicated.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier / placeholder	Use per payer instructions when no additional modifier is required (note: not a CMS standard for reporting; included in input list as available option).

Taxonomy Code	Specialty	Notes
207RH0000X	Rheumatology	Rheumatologists commonly order `0522U` when evaluating suspected Sjögren’s disease.
208D00000X	Diagnostic Radiology	Radiologists may perform salivary gland imaging adjunctive to serologic testing in workup.
207L00000X	Allergy & Immunology	Allergy/immunology specialists may order advanced serologic testing for autoimmune dry mouth/eyes.
208000000X	Pathology	Pathologists oversee laboratory test performance, QA, and reporting in clinical laboratories.
364S00000X	Laboratory Medicine	Clinical laboratory specialists and medical directors supervise and validate proprietary assays like `0522U`.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M35.0`	Sicca syndrome [Sjögren]	Primary diagnostic code for Sjögren’s disease; direct indication for ordering `0522U`.
`K11.7`	Disturbances of salivary secretion, not elsewhere classified	Used when patients present with dry mouth symptoms prompting salivary-specific antibody testing.
`H04.12`	Dry eye syndrome, bilateral	Symptom-driven diagnosis often prompting evaluation for underlying autoimmune causes including Sjögren’s.
`R53.83`	Other fatigue	Nonspecific systemic symptom frequently associated with Sjögren’s and part of the clinical picture.
`M35.9`	Systemic involvement of connective tissue disease, unspecified	Used when autoimmune connective tissue disease is suspected but not yet fully classified; supports broader autoimmune testing including `0522U`.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`86141`	Antinuclear antibodies (ANA) by fluorescent or equivalent technique	Common initial serologic test for autoimmune disease; often ordered concurrently to screen for autoimmunity when evaluating for Sjögren’s.
`86431`	Immunoassay for IgG, IgA, IgM antibodies; single-step method (e.g., ELISA)	Represents standard laboratory immunoassay methods used for autoantibody detection; relates as a conventional alternative or complementary testing methodology.
`87899`	Unlisted infectious disease test	Occasionally used for novel or unique laboratory tests when no specific PLA code exists; `0522U` supersedes the need for an unlisted code for this proprietary assay.
`83516`	Immunoassay for tumor markers, qualitative or semiquantitative; multiple-step method	Example of an automated immunoassay CPT; included as a commonly performed laboratory immunoassay code in workflows involving serologic testing.
`82542`	Assay of salivary components (not otherwise classified) — hypothetical illustrative laboratory chemistry tests	Performed in specialized centers evaluating salivary proteins and may be part of comprehensive salivary diagnostics when assessing Sjögren’s disease.

OpenPayer

Summary & Overview